Search Medical Condition
Please enter condition
Please choose location

Miscarriage Clinical Trials

A listing of Miscarriage medical research trials actively recruiting patient volunteers. Search for closest city to find more detailed information on a research study in your area.

RESULTS

Found (7) clinical trials

This research is being done to compare how well one medicine (misoprostol) alone works to how well that same medicine works if we pre-treat with an additional medicine (mifepristone). Misoprostol alone is currently a standard treatment for women who wish to take medication to help pass a miscarriage pregnancy without ...

Phase

Evaluation of the Safety and Efficacy of GB-0998 in Unexplained Primary Recurrent Miscarriage

To estimate the safety and efficacy of intravenous immunoglobulin therapy using GB-0998 in women with four or more miscarriages by carrying out randomized, placebo-controlled, double-blinded study.

Phase

EmbryoGen/ Blastgen for Couples With Implantation Problems or Previous Miscarriage

A randomised control pilot study will be undertaken for 100 women who have implantation failure (≥ 2 embryo transfers without a pregnancy) or at least 1 previous miscarriage and are having a further IVF cycle. At oocyte retrieval each couple will be randomised using numbered envelopes containing pre randomised group ...

Phase

Intralipid for Recurrent Miscarriage

Intralipid infusion can improve the outcome in NK cells positive females with history of recurrent miscarriages undergoing IVF/ICSI cycles.

Phase

Maternal KIR and Fetal HLA-C Genes in Recurrent Miscarriages

Little is known about reasons for early pregnancy failures. It is believed that some pathology leading to defective implantation of fetus in maternal uterus may lead to recurrent early miscarriages. This project arises from previous work on pre-eclampsia where we found combination of maternal immune genes (KIR) with their ligand ...

Phase N/A

Non-interventional Study of Therapy for Threatened Miscarriage

Open comparative non-interventional study. During the study three visits are planned: Visit 1 (enrollment) is conducted when the patient is hospitalized in a hospital (providing medical care to pregnant women diagnosed with threatened miscarriage) due to the threat of miscarriage when the inclusion/exclusion criteria are met (women aged 18-35 years ...

Phase N/A

Role of Hypersensitivity to Female Sex Hormones in Women With Unexplained Recurrent Pregnancy Loss

The EVE- technology is intended for determination of intolerance or sensitivity to female sex hormones among women with hormone-related conditions and for further treatment by desensitization procedure inducing a tolerance to the hormones the women are sensitive to. This study is designed to evaluate the safety and the ability of ...

Phase